DHS Opioid Detection Resilience Act of 2020
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
DHS Opioid Detection Resilience Act of 2020
This bill establishes new requirements related to the detection of illicit narcotics at ports of entry.
Specifically, U.S. Customs and Border Protection (CBP) must implement a strategy to ensure chemical screening devices are able to identify narcotics at purity levels equal to or less than 10%, or provide an alternate method for identifying narcotics at lower purity levels. The CBP must also test new chemical screening devices at various purity levels before it commits to their acquisition.
Additionally, the Department of Homeland Security must implement a plan for the long-term development of a centralized spectral database for chemical screening devices.
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 3250: DHS Opioid Detection Resilience Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-S-3250/
"S. 3250: DHS Opioid Detection Resilience Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-3250/.
S. 3250, 116th Cong. (2026), https://openamerica.io/bill/116-S-3250/.
[S. 3250: DHS Opioid Detection Resilience Act of 2020](https://openamerica.io/bill/116-S-3250/)